International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R. Sperr, Peter Valent, Karoline V. Gleixner et al.|The Lancet Haematology|2019Cited by 140
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová et al.|Allergy|2020Cited by 77
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on MastocytosisElisabeth Aberer, Peter Valent, Wolfgang R. Sperr et al.|Journal of Investigative Dermatology|2021Cited by 30
Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)Wolfgang R. Sperr, Peter Valent, Michael Kundi et al.|Blood|2016Cited by 5